Contact Us

Supporting your rapid test's growth with consistency and efficiency

Peace-of-mind lateral flow manufacturing solutions assuring product consistency and a security of supply.

Overcoming decentralised molecular testing barriers with lateral flow

Abingdon Health spoke with a leading virologist about why nucleic acid lateral flow assays are vital for deploying decentralised molecular tests.

UK Government confirms order for 1M COVID-19 rapid antibody tests

UK Government enters into a contract for the supply of COVID-19 rapid antibody tests and places its first order for one million AbC-19 Rapid Tests.

£1M funding for the development of a quantitative lateral flow Smartphone Reader

Innovate UK has released £1M to fund a further next generation development of Abingdon Health’s lateral-flow rapid test readout technology; AppDx®.

Several career opportunities for immediate start

Visit our careers page to learn about the job opportunities across the business.

The Latest from Abingdon Health

Company News

December 15, 2020

Admission on AIM market of the London Stock Exchange

Product News

November 17, 2020

Abingdon Health completes FDA Section IV.D notification process

Today we announce the admission of our share capital to trading on the #AIMmarket of the London Stock Exchange. Dealings in ordinary shares have commenced under the ticker $ABDX. Read the full details here: abingdonhealth.com/admission-aim-… #IPO #LSE

Don't forget Abingdon Health will be speaking at today's @MedilinkNOE @ukCPI webinar on ‘Overcoming challenges to digitising medical devices' at 13:40 GMT. Register: bit.ly/2KzQJ2L #MedTech #NHS #Webinar